PIIIP3 Health Partners Inc.

$9.05

The financials

P3 Health Partners Inc. by the numbers

P3 Health Partners Inc. (PIII) reported revenue of $386M in Q1 2026 (quarter ended Mar 31, 2026), up 3.5% from the same quarter a year earlier. That came with net income of $1.2M (0.3% of revenue). For the full year FY2025, revenue was $1.46B (−2.8% year on year) and net income −$148M. Its largest product in Jun 2026 was Capitated at $366M, 90% of the disclosed total, well ahead of Health Care Patient Service at 4.9%.

P3 Health Partners Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$386M$373M+3.5%
Operating income$8.2M−$38Mto a profit
Net income$1.2M−$20Mto a profit
Diluted EPS$0.32−$6.28to a profit
Revenue by product, Jun 2026, as reported to the SEC
ProductRevenueShare
Capitated$366M90%
Health Care Patient Service$20M4.9%
Health Care Incentive Fees$10M2.6%
Health Care Care Coordination Management Fees$8.8M2.2%
Health Care Clinical Fees Insurance$856K0.2%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $406.4M (+3.3%)
Health Care Incentive Fees grew +1660% year on yearCapitated +4.2% year on year
  • Capitated$366.4MQoQ -3.5%year on year +4.2%
  • Health Care Patient Service$20.0MQoQ +190%year on year +392%
  • Health Care Incentive Fees$10.4MQoQ +9326%year on year +1660%
  • Health Care Care Coordination Management Fees$8.8MQoQ +34%year on year +228%
  • Health Care Clinical Fees Insurance$856.0KQoQ +225%year on year +5.9%
Segment sum = 105% of reported consolidated revenue · Latest source: 10-Q filed 2026-08-10, SEC EDGAR